Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andrew Bruce Onderdonk, Ph.D.

Co-Author

This page shows the publications co-authored by Andrew Onderdonk and Dennis Kasper.
Connection Strength

1.666
  1. Chalabaev S, Anderson CA, Onderdonk AB, Kasper DL. Sensitivity of Francisella tularensis to ultrapure water and deoxycholate: implications for bacterial intracellular growth assay in macrophages. J Microbiol Methods. 2011 Jun; 85(3):230-2.
    View in: PubMed
    Score: 0.129
  2. Onderdonk AB, Cisneros RL, Finberg R, Crabb JH, Kasper DL. Animal model system for studying virulence of and host response to Bacteroides fragilis. Rev Infect Dis. 1990 Jan-Feb; 12 Suppl 2:S169-77.
    View in: PubMed
    Score: 0.119
  3. Onderdonk AB, Cisneros RL, Crabb JH, Finberg RW, Kasper DL. Intraperitoneal host cellular responses and in vivo killing of Bacteroides fragilis in a bacterial containment chamber. Infect Immun. 1989 Oct; 57(10):3030-7.
    View in: PubMed
    Score: 0.117
  4. Kasper DL, Finberg RF, Crabb J, Onderdonk AB. Immune mechanisms in the prevention of intra-abdominal abscess formation. Scand J Infect Dis Suppl. 1989; 62:29-34.
    View in: PubMed
    Score: 0.111
  5. Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Commentary: Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis 1977; 136:701. J Infect Dis. 2004 Jul 01; 190(1):202-9.
    View in: PubMed
    Score: 0.081
  6. Onderdonk AB, Shapiro ME, Finberg RW, Zaleznik DF, Kasper DL. Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis. Rev Infect Dis. 1984 Mar-Apr; 6 Suppl 1:S91-5.
    View in: PubMed
    Score: 0.079
  7. Kasper DL, Onderdonk AB. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model. Scand J Infect Dis Suppl. 1982; 31:28-33.
    View in: PubMed
    Score: 0.068
  8. Onderdonk AB, Markham RB, Zaleznik DF, Cisneros RL, Kasper DL. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model. J Clin Invest. 1982 Jan; 69(1):9-16.
    View in: PubMed
    Score: 0.068
  9. Tzianabos AO, Finberg RW, Wang Y, Chan M, Onderdonk AB, Jennings HJ, Kasper DL. T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria. J Biol Chem. 2000 Mar 10; 275(10):6733-40.
    View in: PubMed
    Score: 0.060
  10. Kalka-Moll WM, Tzianabos AO, Wang Y, Carey VJ, Finberg RW, Onderdonk AB, Kasper DL. Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity. J Immunol. 2000 Jan 15; 164(2):719-24.
    View in: PubMed
    Score: 0.060
  11. Tzianabos AO, Russell PR, Onderdonk AB, Gibson FC, Cywes C, Chan M, Finberg RW, Kasper DL. IL-2 mediates protection against abscess formation in an experimental model of sepsis. J Immunol. 1999 Jul 15; 163(2):893-7.
    View in: PubMed
    Score: 0.058
  12. Comstock LE, Coyne MJ, Tzianabos AO, Pantosti A, Onderdonk AB, Kasper DL. Analysis of a capsular polysaccharide biosynthesis locus of Bacteroides fragilis. Infect Immun. 1999 Jul; 67(7):3525-32.
    View in: PubMed
    Score: 0.057
  13. Tzianabos AO, Kasper DL, Cisneros RL, Smith RS, Onderdonk AB. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis. J Clin Invest. 1995 Dec; 96(6):2727-31.
    View in: PubMed
    Score: 0.045
  14. Tzianabos AO, Kasper DL, Onderdonk AB. Structure and function of Bacteroides fragilis capsular polysaccharides: relationship to induction and prevention of abscesses. Clin Infect Dis. 1995 Jun; 20 Suppl 2:S132-40.
    View in: PubMed
    Score: 0.043
  15. Tzianabos AO, Onderdonk AB, Zaleznik DF, Smith RS, Kasper DL. Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation. Infect Immun. 1994 Nov; 62(11):4881-6.
    View in: PubMed
    Score: 0.042
  16. Tzianabos AO, Onderdonk AB, Kasper DL. Bacterial structure and functional relation to abscess formation. Infect Agents Dis. 1994 Oct; 3(5):256-65.
    View in: PubMed
    Score: 0.041
  17. Tzianabos AO, Onderdonk AB, Smith RS, Kasper DL. Structure-function relationships for polysaccharide-induced intra-abdominal abscesses. Infect Immun. 1994 Aug; 62(8):3590-3.
    View in: PubMed
    Score: 0.041
  18. Tzianabos AO, Onderdonk AB, Rosner B, Cisneros RL, Kasper DL. Structural features of polysaccharides that induce intra-abdominal abscesses. Science. 1993 Oct 15; 262(5132):416-9.
    View in: PubMed
    Score: 0.039
  19. Pantosti A, Tzianabos AO, Reinap BG, Onderdonk AB, Kasper DL. Bacteroides fragilis strains express multiple capsular polysaccharides. J Clin Microbiol. 1993 Jul; 31(7):1850-5.
    View in: PubMed
    Score: 0.038
  20. Rodewald AK, Onderdonk AB, Warren HB, Kasper DL. Neonatal mouse model of group B streptococcal infection. J Infect Dis. 1992 Sep; 166(3):635-9.
    View in: PubMed
    Score: 0.036
  21. Pantosti A, Tzianabos AO, Onderdonk AB, Kasper DL. Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis. Infect Immun. 1991 Jun; 59(6):2075-82.
    View in: PubMed
    Score: 0.033
  22. Crabb JH, Finberg R, Onderdonk AB, Kasper DL. T cell regulation of Bacteroides fragilis-induced intraabdominal abscesses. Rev Infect Dis. 1990 Jan-Feb; 12 Suppl 2:S178-84.
    View in: PubMed
    Score: 0.030
  23. Breeling JL, Onderdonk AB, Cisneros RL, Kasper DL. Bacteroides vulgatus outer membrane antigens associated with carrageenan-induced colitis in guinea pigs. Infect Immun. 1988 Jul; 56(7):1754-9.
    View in: PubMed
    Score: 0.027
  24. Zaleznik DF, Zhang ZL, Onderdonk AB, Kasper DL. Effect of subinhibitory doses of clindamycin on the virulence of Bacteroides fragilis: role of lipopolysaccharide. J Infect Dis. 1986 Jul; 154(1):40-6.
    View in: PubMed
    Score: 0.023
  25. Zaleznik DF, Finberg RW, Shapiro ME, Onderdonk AB, Kasper DL. A soluble suppressor T cell factor protects against experimental intraabdominal abscesses. J Clin Invest. 1985 Mar; 75(3):1023-7.
    View in: PubMed
    Score: 0.021
  26. Kasper DL, Lindberg AA, Weintraub A, Onderdonk AB, Lönngren J. Capsular polysaccharides and lipopolysaccharides from two strains of Bacteroides fragilis. Rev Infect Dis. 1984 Mar-Apr; 6 Suppl 1:S25-9.
    View in: PubMed
    Score: 0.020
  27. Kasper DL, Onderdonk AB, Reinap BG, Linberg AA. Variations of Bacteroides fragilis with in vitro passage: presence of an outer membrane-associated glycan and loss of capsular antigen. J Infect Dis. 1980 Nov; 142(5):750-6.
    View in: PubMed
    Score: 0.016
  28. Kasper DL, Onderdonk AB, Crabb J, Bartlett JG. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis. J Infect Dis. 1979 Nov; 140(5):724-31.
    View in: PubMed
    Score: 0.015
  29. Kasper DL, Onderdonk AB, Polk BF, Bartlett JG. Surface antigens as virulence factors in infection with Bacteroides fragilis. Rev Infect Dis. 1979 Mar-Apr; 1(2):278-90.
    View in: PubMed
    Score: 0.014
  30. Mansheim BJ, Onderdonk AB, Kasper DL. Immunochemical characterization of surface antigens of Bacteroides melaninogenicus. Rev Infect Dis. 1979 Mar-Apr; 1(2):263-77.
    View in: PubMed
    Score: 0.014
  31. Onderdonk AB, Kasper DL, Mansheim BJ, Louie TJ, Gorbach SL, Bartlett JG. Experimental animal models for anaerobic infections. Rev Infect Dis. 1979 Mar-Apr; 1(2):291-301.
    View in: PubMed
    Score: 0.014
  32. Gibson FC, Onderdonk AB, Kasper DL, Tzianabos AO. Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis. J Immunol. 1998 May 15; 160(10):5000-6.
    View in: PubMed
    Score: 0.013
  33. Onderdonk AB, Moon NE, Kasper DL, Bartlett JG. Adherence of Bacteroides fragilis in vivo. Infect Immun. 1978 Mar; 19(3):1083-7.
    View in: PubMed
    Score: 0.013
  34. Mansheim BJ, Onderdonk AB, Kasper DL. Immunochemical and biologic studies of the lipopolysaccharide of Bacteroides melaninogenicus subspecies asaccharolyticus. J Immunol. 1978 Jan; 120(1):72-8.
    View in: PubMed
    Score: 0.013
  35. Kasper DL, Onderdonk AB, Bartlett JG. Quantitative determination of the antibody response to the capsular polysaccharide of Bacteroides fragilis in an animal model of intraabdominal abscess formation. J Infect Dis. 1977 Dec; 136(6):789-95.
    View in: PubMed
    Score: 0.013
  36. Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis. 1977 Nov; 136(5):701-5.
    View in: PubMed
    Score: 0.013
  37. Kasper DL, Hayes ME, Reinap BG, Craft FO, Onderdonk AB, Polk BF. Isolation and identification of encapsulated strains of Bacteroides fragilis. J Infect Dis. 1977 Jul; 136(1):75-81.
    View in: PubMed
    Score: 0.012
  38. Onderdonk AB, Kasper DL, Cisneros RL, Bartlett JG. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J Infect Dis. 1977 Jul; 136(1):82-9.
    View in: PubMed
    Score: 0.012
  39. Shapiro ME, Kasper DL, Zaleznik DF, Spriggs S, Onderdonk AB, Finberg RW. Cellular control of abscess formation: role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis. J Immunol. 1986 Jul 01; 137(1):341-6.
    View in: PubMed
    Score: 0.006
  40. Shapiro ME, Onderdonk AB, Kasper DL, Finberg RW. Immune T cells prevent bacteroides fragilis abscesses. Curr Surg. 1983 Mar-Apr; 40(2):123-6.
    View in: PubMed
    Score: 0.005
  41. Shapiro ME, Onderdonk AB, Kasper DL, Finberg RW. Cellular immunity to Bacteroides fragilis capsular polysaccharide. J Exp Med. 1982 Apr 01; 155(4):1188-97.
    View in: PubMed
    Score: 0.004
  42. Bartlett JG, Onderdonk AB, Louie T, Kasper DL, Gorbach SL. A review. Lessons from an animal model of intra-abdominal sepsis. Arch Surg. 1978 Jul; 113(7):853-7.
    View in: PubMed
    Score: 0.003
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.